tirzepatide surmount-1 weight loss percent 72 weeks before and after: realistic results, timelines, and what to expect NEJM on X: "SURMOUNT-1: In

Oct 26: Eli Lilly won FDA approval Thursday for Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active ulcerative colitis (UC), marking the companys first approved drug for a type of inflammatory bowel disease

Tirzepatide increases your chances of getting pregnant through two separate mechanisms

Standard dose escalation The typical tirzepatide dose escalation schedule progresses as follows: Weeks 1-4: 2.5mg once weekly Weeks 5-8: 5.0mg once weekly Weeks 9-12: 7.5mg once weekly Weeks 13-16: 10.0mg once weekly Weeks 17-20: 12.5mg once weekly Weeks 21+: 15.0mg once weekly (maximum dose) This gradual escalation allows the body to adapt to each dose level, minimizing gastrointestinal side effects that commonly occur when starting or increasing the dose

References Och, A., Och, M., Nowak, R., Podgrska, D., & Podgrski, R

Both Semaglutide and Tirzepatide are available in three formats through Ellie MD: weekly injections, oral drops, and microdosing

Starting Your Semaglutide Treatment Initial Dosage: What to Expect in the First Few Weeks In the initial weeks, youll typically begin with a lower dose of semaglutide